Compliance and hypertension

被引：22

作者：

Garfield F.B. ^{[1
]}

Caro J.J. ^{[1
]}

机构：

[1] Caro Research, Concord, MA 01742

来源：

Current Hypertension Reports | 1999年 / 1卷 / 6期

关键词：

Behavior Change; Health Belief; Health Belief Model; Medication Characteristic; Reason Action Approach;

D O I：

10.1007/s11906-996-0022-y

中图分类号：

学科分类号：

摘要：

Despite decades of attention to noncompliance to treatment for hypertension, the problem remains a significant factor in the inadequate control of blood pressure. Current approaches to enhancing compliance use patient demographics, medication characteristics, clinical factors, health beliefs, and the quality of patient-provider communication. Clinical researchers are just beginning to apply a new approach that views compliance as a behavior change taking place over time. In this view, patients do not simply change their behavior through a one-time decision to take their medication as directed by their physicians; they move through five stages of behavior change. Clinicians can increase compliance by assessing their patients to determine the patient's stage of behavior change, then matching their interventions to that stage. Copyright © 1999 by Current Science Inc.

引用

页码：502 / 506

页数：4

共 42 条

[1]

Hill M.N., Miller N.H., Compliance enhancement, a call for multidisciplinary team approaches, Circulation, 93, pp. 4-6, (1996)

[2]

Rudd P., Ahmed S., Zachary V., Et al., Antihypertensive drug trials, contributions from medication monitors, Patient Compliance in Medical Practice and Clinical Trials, pp. 283-299, (1991)

[3]

Urquhart J., When outpatient drug treatment fails: Identifying noncompliers as a cost containment tool, Medical Interface, 6, pp. 65-73, (1993)

[4]

Bittar N., Maintaining long-term control of blood pressure: The role of improved compliance, Clin Cardiol, 18, (1995)

[5]

Juncos L.I., Patient compliance and angiotensin-converting enzyme inhibitors in hypertension, J Cardiovasc Pharmacol, 15, SUPPL. 3, pp. 22-25, (1990)

[6]

Caro J.J., Speckman J.L., Existing treatment strategies: Doe noncompliance make a difference, J Hypertens, 16, SUPPL. 7, pp. 31-34, (1998)

[7]

1998 Heart and Stroke Statistical Update, (1997)

[8]

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI), Arch Intern Med, 157, pp. 2413-2446, (1997)

[9]

Eichert J.H., Wong H., Smith D.R., The disease management development process, Disease Management: A Systems Approach to Improving Patient Outcomes, pp. 27-60, (1997)

[10]

Sullivan S.D., Kreling D.H., Hazlet T.K., Noncompliance with medication regimens and subsequent hospitalizations: A literature analysis and cost of hospitalization estimate, J Research in Pharmaceutical Economics, 2, pp. 19-33, (1990)

← 1 2 3 4 5 →